oxford astrazeneca trial in children. ., oxford astrazeneca trial in children-— oxford astrazeneca trialhildren. you mentioned that by the time we get around _ children. you mentioned that by the time we get around to _ children. you mentioned that by the time we get around to vaccinating i time we get around to vaccinating younger age groups there may be other vaccines in play, anyway. and let's talk about moderna being rolled out in the uk for the first time today in wales. what do we know about this particular vaccine, its efficacy and how it fits into the wider vaccination programme? yeah, well, it's actually _ wider vaccination programme? yeah, well, it's actually very, _ wider vaccination programme? yeah, well, it's actually very, very - well, it's actually very, very similar to the pfizer vaccine. it's produced in roughly the same way and it works in exactly the same way as the pfizer vaccine. and when you look at the results of the phase three trials, it's very difficult, until you see the title on the top of the paper, to work out which data comes from witch trials, the results

the oxford scientists say _ we talking about? the oxford scientists say this _ we talking about?scientists say this is - we talking about? the oxford scientists say this is being - we talking about? the oxford l scientists say this is being done out of an abundance of caution and there are no safety concerns in the volunteers but they thought it would be sensible to stop vaccinating while this adult review is going on. no medicine whether it is paracetamol or vaccines is risk—free but unpicking whether there is a link between the astrazeneca jab and these incredibly rare blood clots is frankly difficult. the incidence in the uk is about one case in every 600,000 vaccinations and in germany it is higher, nearly all involving young women, in each case has to be investigated. did those involved have underlying conditions? did they have underlying conditions? did they have covid which increases your risk of blood clots and is there a connection between them? we know that there is an all too real risk from covid especially amongst the elderly, and for those in their 40s, for example,

let's get more on our top story on the oxford—astrazeneca vaccine.erns over blood clots. dr maggie wearmouth, who sits on thejoint committee on vaccination and immunisation said the issue was about safety and public confidence. earlier i spoke to paul hunter, professor in medicine at the university of east anglia, and i asked him why there are concerns about the safety of the oxford—astrazeneca vaccine. i think one of the concerns always with something like a mass roll—out of any medication or vaccine is that you will see clusters of cases following that intervention that could arise entirely by chance. the problem is that once you start seeing that in multiple geographical regions with the same disease following the same intervention, then i think that the odds are more that it's going to be actually related rather than some sort of statistical glitch. and added to that the fact that we were only really seeing this condition in people following the oxford—astrazeneca vaccine and not at all really seeing it in people following the pfizer vaccine. i t

cambridge edged in front and, while oxford pushed them, they failed to reel them in. on home water, it is still theirs. cambridge have the victory. a double victory then for cambridge in a year unlike any other — time to toast a new chapter in this

, johnson &johnson and oxford, johnson & johnson and maybe oxford, johnson &johnson and maybe even thea few days to get around it is warranted. years ago this would not be such a big deal, but we now have a new world with a very aggressive anti—vaccine landscape and that makes it more complicated and problematic.— more complicated and problematic. more complicated and roblematic. , . ., problematic. yes, we will come to that in _ problematic. yes, we will come to that in a _ problematic. yes, we will come to that in a second. _ problematic. yes, we will come to that in a second. it _ problematic. yes, we will come to that in a second. it sounds . to that in a second. it sounds as if you expect the numbers to go up. i as if you expect the numbers to no u. ~' as if you expect the numbers to .o u, ~' �* , ., go up. i think it's a possibility. - go up. i think it's a - possibility. remember, we go up. i think it's a _ possibility. remember, we could go from six to 12 cases but that's still going to be a pretty uncommon number. the rates looking at europe, one in 100,000, one in 250,000 in

we are reporting from oxford street. we are seeing optimism and excitement in london and england about the reopening. we are not seeing that across global equity markets. futures across-the-board are in the red even though we have another all-time high in europe and the united states on friday. i brought up china. we are down one point 5%. alibaba is rallying. 1.5 6% on the 10-year. and then the pound, 136.73, down .25%. the question manus brought up earlier, the euro doing well but not so much the pound. warning us now to break this all down is the senior currency strategy for cba europe. let's start there. is that hot trade we saw early on this year and towards the end of last year, is that starting to? --to lose favor? >> the pound faces a little bit of headwind against the dollar for the pound. it faces headwinds because of nominal bond yield differentials between the u.s. and the u.k. and then against the euro, it faces short-term headwinds because it's relatively overvalued relative to the euro but beyond this near

still to come: oxford and cambridge, just messing about on the river.p up on the statue. this funeral became a massive demonstration of black power, the power to influence. today is about the promise of a bright future, a day when we hope a line can be drawn under the bloody past. i think that picasso's i works were beautiful, they were intelligent, and it's a sad loss - to everybody who loves art. this is bbc news, the latest headlines... royal crisis injordan — former crown prince hamza says he's under house arrest. he's accused of being involved in a plot to destabilise the country. the pope uses his easter sunday address to call for covid vaccines to be shared with the world's poorest countries. aid groups in mozambique say nearly 10,000 people have been evacuated from the northern town of palma, which was recently attacked by islamist militants. the mozambican authorities say thousands are still hiding in the forests surrounding the area, in desperate need of food and water. the plant is reported to have come under militant ——the bbc�*s vumani mkhi

first, what is the risk with oxford—astrazeneca?e, as the potential for serious illness with covid is weighed against potential harms from blood clots. the official advice is that anyone who has had a firstjab and four days or more after that gets severe headaches, blurred vision or certain other symptoms, should contact a medical professional. a committee of europe's regulator, known as prac, drew this conclusion. we know the benefits of the astrazeneca vaccine have been established. it prevents covid disease, it prevents hospitalisation and it prevents mortality. so in that respect, prac feels that the overall benefits outweigh the risks. so will it delay the vaccine roll—out? health officials say even with under—30s given a choice of alternative jabs, they're still on course to offer all adults a first dose by the end ofjuly. so the road map should stay the same. although it does depend on supplies currently promised. of the vaccines currently in use, the government ordered 100 million doses from oxford—astrazeneca. though the ro

oxford vaccine and shelved thejohnson & astrazeneca oxford vaccine and shelved the johnson & johnsonejohnson &johnson vaccine, it may shelved the johnson & johnson vaccine, it may not have that much impact on the us programme because they have other options, they have procured so much of the mrna vaccines and the particle vaccine may still be there. but the problem when you look at sub—saharan africa and latin america, they are all adenovirus vector vaccines, and if somebody signals a problem oran if somebody signals a problem or an alarm, that could have a devastating effect on the ability of africa and latin america to fight this pandemic. so it is so important how we operate and proceed, not only thinking about the safety of the american people but thinking about the world. us presidentjoe biden has urged russian president vladimir putin to ease tensions on the ukrainian border and suggested they hold their first summit. this comes as tensions rise over russia's military build—up next to ukraine. bbc north america correspondent aleem maqbool reports. it's the biggest russian troop

first, what is the risk with oxford—astrazeneca? serious illness with covid is weighed against potential harms from blood clots. the official advice is for anyone who has had a firstjab and four days or more after that gets severe headaches, blurred vision or certain other symptoms, should contact a medical professional. a committee of europe's regulator, known as pr ac, to this conclusion. we know the benefits of the astrazeneca vaccine have been established. it prevents covid disease, it prevents hospitalisation and it prevents mortality. so in that respect prac feels that the overall benefits outweigh the risks. so will it delay the vaccine rollout? health officials say even with under 30s given a choice of alternative jabs, they're still course to offer all adults a first dose by the end ofjuly. so the road map should stay the same. although it does depend on supplies currently promised. of the vaccines currently in use, the government ordered 100 million doses of oxford—astrazeneca. though the rollout will slow down this month

we have the figures announced today 20000000 people as i said have been given the 1st dose of the oxford astra zeneca vaccine all of those there were 79 cases of these rat blood clots after the people received the 1st dose and all of that 19 people died now it's thought to be equal amounts about one in a 1000000 people one of a 1000000 chance of dying off receiving this vaccine so i think to say that people at the young people have dodged a bullet by by this hearing this announcement is is going is going too far just to stress again the benefits here we've been told over and over again fall far outweigh the risks and we know the leads europe when we're talking about the drive to vaccinate people so what does today's warning what does it do to the n.h.s. has plans for vaccinations moving forward do we know. well there are 2 ways of answering this question there are there is of course the vaccine roll out and there is the planned easing of restrictions which is underway at the moment with more strictures expected to be knocked on restrictions expected to be eased here on monday and the ans

the oxford—astrazeneca coronavirus vaccine trial on children and teenagers is temporarily paused tonight as the uk regulator investigates whether there is a possible link with rare blood clots in adults. oxford university say they won't carry out more jabs on younger people "out of an abundance of caution". more data is due to be published in the coming days — the world health organization says the vaccine�*s benefit largely outweighs the risk. forthe time being, there is no evidence that the benefit risk assessment for the vaccine needs to be changed. the argument continues over so—called covid passports — and what they might be needed for. the disappearance of 19 —year—old richard okorogheye — a body is about to be formally identified. fresh calls to deport members of a notorious rochdale grooming gang after one of the men was spotted in the town where he abused young girls more than a decade ago. also coming up... tributes to the actor paul ritter — best known for his role in �*friday night dinner�* — who's died of a brain tumour at the age of 5a. a trial of the oxford—astrazeneca cor

first, what is the risk with oxford—astrazeneca? lower the older you are, as the potential for serious illness with covid is weighed against possible harms from blood clots. some medication, including the contraceptive pill, also has a very small blood clot risk. anyone who has had a firstjab and four days or more after that gets severe headaches, blurred vision or certain other symptoms should contact a medical professional. a committee of europe's regulator, known as prac, drew this conclusion. we know the benefits of the astrazeneca vaccine have been established. it prevents covid disease, it prevents hospitalisation and it prevents mortality. so in that respect prac feels that the overall benefits outweigh the risks. so will it delay the vaccine rollout? today a newjab was delivered for the first time in wales and scotland, made by the us company moderna. it is set to be offered elsewhere in the uk from next week. health officials say even with under 30s given a choice of alternative jabs, they're still on course to offer all ad

this and the oxford astrazeneca “ab? this is the and the oxford astrazeneca jab?e pfizer or madonna —— modern jab instead. we are still on track to offer the vaccine to all adults by the end ofjuly, but it does mean that we are taking this in the safest way possible to save as many lives as possible, as quickly as possible. that is the goal and i'm very grateful to these world class regulators who can spot this extremely rare events. i class regulators who can spot this extremely rare events.— class regulators who can spot this extremely rare events. i wonder if ou can extremely rare events. i wonder if you can take _ extremely rare events. i wonder if you can take us— extremely rare events. i wonder if you can take us through _ extremely rare events. i wonder if you can take us through some i extremely rare events. i wonder if you can take us through some of. extremely rare events. i wonder if i you can take us through some of the practicalities. you said those under 30 will be offered the opportunity to have an alternative vaccine. how will it work in practice?

regulators have concluded there is a plausible link between the oxford astra zeneca covered 19 vaccine and rare blood clots but they insist the risk of the corona virus is fog greater than the risk posed by tossing india has announced another record number of new cases more than 126000 covered 19 infections were reported in the last 24 hours new delhi mumbai and dozens of other cities are imposing night curfews the government says people still are not complying enough with ma schools and social distancing. the number of coronavirus deaths in brazil has dipped slightly from the record high of 4200 announced on tuesday another 3800 deaths were reported on wednesday with around 92000 new infections president continues to play down covert 19 and has rejected the idea of a national lockdown an expert in the use of force has testified at the trial of the former police officer who's accused of killing george floyd jodie steiger said derrick shelve and used inappropriate deadly force when kneeling on floyd's neck for more than 9 minutes. the u.s. says agreed to withdraw all remaining combat fo

the oxford astra zeneca vaccine under uncomfortable scrutiny medicines regulators in the u.k. and the e.u. have judged that its benefits outweigh any possible risks but they haven't ruled out a causal link between the vaccine and rare blood clot conditions in a tiny number of recipients based on the current evidence the benefits of the covert 900 facts in astra zeneca against covert 90 and its associated risks hospitalization and death continues to outweigh the risks for the vast majority of people. our review has reinforced that the risk of this fred suspected side effect remains extremely small in arms today the european medicines agency said there was insufficient data to isolate risk factors like age and gender and that blood clotting should be listed as a possible side effect of the jab this case also shows us that our pharmacovigilance system is working these very rare and unusual events have been picked up identified analyzed and loudest to come to science based recommendations to allow the safe and effective use of this vaccine investigations into the astra zeneca vacc

first, what is the risk with oxford—astrazeneca?er you are, as the potential for serious illness with covid is weighed against possible harms from blood clots. some medication, including the contraceptive pill, also has a very small blood clot risk. anyone who has had a firstjab and four days or more after that gets severe headaches, blurred vision or certain other symptoms should contact a medical professional. a committee of europe's regulator, known as prac, drew this conclusion. we know the benefits of the astrazeneca vaccine have been established. it prevents covid disease, it prevents hospitalisation and it prevents mortality. so in that respect prac feels that the overall benefits outweigh the risks. so will it delay the vaccine roll—out? today a newjab was delivered for the first time in wales and scotland, made by the us company moderna. it is set to be offered elsewhere in the uk from next week. health officials say even with under 30s given a choice of alternative jabs, they're still on course to offer all adults a first

so, you will remember last month the ema issued guidance which said the benefits of taking the oxfordsaid any causal link between these extremely rare blood clots and the vaccine were possible but not proven, and the evidence suggested that people should continue to take it. we've seen governments across the eu adopting different approaches though — some, including here in the netherlands and across the border in germany, have paused the use of the astrazeneca jab among the under—60s. in france, it's the under—55s. so what we are expecting from the ema today, they have continued to investigate the data as it emerges from around the world, and we are expecting an update on whether there is a possible link and whether they may update their guidance to list blood clots as among the side—effects, and then it will be up to the eu governments to decide what to do with that information. but it hasn't helped with the public confidence issue — that is one of the main obstacles here on the continent, along with the supply of these vaccines. so the ema guidance is expected this afternoon, eagerl

a trial of the oxford—astrazeneca vaccine on children is suspended in the uk, while the country's regulatorestigates possible links to rare blood clots in adults. russian police detain supporters ofjailed kremlin critic, alexei navalny, amid reports he is suffering from a respiratory illness. one is fun — why so many of china's parents are limiting themselves to a single child, despite now being allowed to have more. translation: for me, - it's already hard to raise this one. it feels better to put all your energy into one child, or we might feel guilty that we can't properly take care of many. hello and welcome if you're watching in the uk or around the world. it's day seven in the trial of former police officer derek chauvin in minneapolis, the man accused of killing george floyd by kneeling on his neck in a case that triggered worldwide protests over racial injustice. today, we've been hearing more evidence from former colleagues of derek chauvin in the police department, with a particular focus on the training that officers receive. our correspondent larry madowo has been following the

university as many people will have heard about the oxford astra zeneca vaccine. is there is this an entirely separate project project or is there some kind of similarity that said mabel that the t. breakthrough is to come at the same sort to be similarity. only similarity is that we did fry that you know carol back to back soon for malaria we got some protection but not close to the certainly certain percent we're seeing today with this new vaccine so this is a next generation malaria vaccine with a new attitude and with a new design to the immunization it serves so in a sense we have not actually been published on this before so it's very exciting to see this really working working 1st time absolutely it's very excited we're seeing all the we're all becoming armchair epidemiologists and experts and vaccines are watching this said whole but now that you find the world just talking about vaccines helping treat these diseases that some of which we've never really heard about before in a more general terms are you more hopeful that we're going to see people more rec

investigations are taking place to see if the oxford—astrazeneca jab may be linked with very red bloodon of features have been picked up in cases detected so far. the interest is that these _ cases detected so far. the interest is that these cases _ cases detected so far. the interest is that these cases are _ cases detected so far. the interest is that these cases are associated l is that these cases are associated with low platelet count which we don't normally see in cases of thrombosis that makes them stand out and it matches cases we have heard from other european countries. for the people being offered the vaccine at the moment the risk/benefit is very strongly in favour of receiving the vaccine if it transpires there is a link between the astrazeneca vaccine and rare blood clots it is estimated it could cause one out of 2.5 million people estimated it could cause one out of 2.5 million peopl— estimated it could cause one out of 2.5 million people vaccinated in the uk. at this stage _ 2.5 million people vaccinated in the uk. at this stage with _ 2.5 million people vaccinated in t

well of course he's a big defend the oxford astra zeneca vaccine the pot in pot i'm sure has a degree of national pride that this being a u.k. swedish company also that has local universities in the development of this so there will be a good deal of pride but there is pride in the entire back scene rolled out the u.k. leading the rest of europe on that now that's in pots due to the fact that the u.k. has ordered a 100000000 doses of 7 different vaccines so that policy is being credited with playing a big role in the u.k. back seeing a role so i think the general feeling here is that the overall picture is the of the vaccine rollout irrespective of this new xbox or that it could see day is still considered a success and rights to be used by current sales until in london tonight charlotte thank you well the 1000 prizes in brazil is getting worse by the day on tuesday for the 1st time brazil reported within 4 sales a new deaths from covert 19 doctors say a local variant of the virus is causing this latest surge which has pushed the health care system to the breaking point. another sorry

here in the uk, a trial of the oxford—astrazeneca vaccine on children has been paused while scientistsossible link with rare blood clots in adults. the university of oxford has told the bbc that there are no safety concerns with the trial itself, but its scientists were waiting for further information. the prime minister boris johnson has urged people to get their vaccination when invited. our medical editor fergus walsh reports. nearly 300 children aged 6—17 are taking part in the astrazeneca vaccine trial in england which began in february. oxford university said there had been no blood clots in the volunteers, but out of an abundance of caution, it had stopped vaccinations, pending the outcome of the safety review in adults. more than 18 million people in the uk have received the astrazeneca vaccine. the mhra said last week there had been 30 rare cases of blood clots including seven deaths. the prime minister, visiting an astrazeneca plant in macclesfield, once again gave his firm support for the vaccine. the best thing people should do is look at what the mhra say, our independent

harry has been keeping tabs on him since the first interview, visiting him at oxford.est extraordinary chapter in the story. >> reporter: he has a lot on his mind. congratulations, first. >> thanks. >> reporter: on your master's from oxford. >> they gave me the paper. it's irrevocable. >> reporter: he is a research associate at the university of south carolina. he is a person with autism. >> i think one of the hallmarks of my experience as an autistic individual has been maybe not a growing comfort level but a growing desire to want to engage with others and learn from others. >> reporter: that engagement includes authoring a new book titled "how to be human." >> what would it mean to think about autism as not just a list of pros and cons. stack them up and one scale is bigger than the other. rather as a difference in thinking. >> reporter: a difference in thinking, not a deficit. his thought processes are based on images. translating images into language is no small task. >> it takes a ton of energy. i mean, i don't know how to describe it other than energy. you can f

a new malaria vaccine developed by the team behind the oxford—astrazeneca jab has proved to be 77% effectiverly trials. and at 5:45, anna smith gives her take on the best and worst of the week's film and dvd releases. that's in the film review. good afternoon and welcome to bbc news. there are calls for a full public inquiry after 39 former subpostmasters who were convicted of theft and false accounting because of a defective post office accounting system were cleared by the court of appeal. it's the uk's most widespread miscarriage ofjustice. some had gone to prison, and many sawjobs, marriages and reputations ruined after being wrongly accused of financial irregularities. the court heard that a computer software system called horizon had problems from the beginning of its installation. the post office has apologised for the impact the scandal has had on the men and women who were convicted. katie prescott reports. unsure whether to laugh or cry. after year of being labelled criminals, some shunned by their communities, even imprisoned, these former postma sters saw their these former postm

when they heard the news when 20000000 people to be exact post office been ranked native with the oxford astra zeneca vaccine and of course any suggestion of a possible link between these red blood clots on the job will be a cause of concern among the people that i've spoken to as you might expect concern high and among younger people that we've been hearing that the risk benefit calculation is very different when looking at a given the japs on just that is that it is to giving the job to those who are older who have more of a risk of ending up being hospitalized or indeed dying from cova 19 so yes there is some concern but the agreement is that any risks hit. the benefits far outweigh any of the risks in fact we were told today by the medicines a regulator that the risk of these potential blood clots is vanishingly small say one of that really has to be to be kept in mind when looking at the the risk associated with this job and we know that people under 30 are being told that maybe they should get a different type of vaccines and we know that people under 30 have not begun to be vaccin

well of course he's a big defend the oxford astra zeneca back in the pot in part i'm sure has a degree of national pride that this thing at a u.k. swedish company also that is well to the universities in the development of this so there will be a good deal of pride but there is pride in the entire boxing rolled out the u.k. leading the rest of europe on that now that's in pots and due to the fact that the u.k. has ordered up a 100000000 doses of 7 different vaccines that up policy is being credited with playing a big role in the u.k. vaccine roll out so i think the general feeling here is that the overall picture is the the vaccine rollout irrespective of this news buster that i could say is still considered a success rights to be used later on that sells until in london tonight charlotte thank you well the 1000 crimes is in brazil is getting worse by the day on tuesday for the 1st time brazil reported within 4 sales of new deaths from coburg 19 doctors say a local variant of the virus is causing this latest surge which has pushed the health care system to the breaking point. another s

- oxford astrazeneca vaccine? yeah, this is a very _ oxford astrazeneca vaccine?a very challenging situation. because we do have an identified, very rare but serious adverse events. and i think what is happening now is good, that people are being informed, and communication has been happening right from the very beginning when a suspicion was a rose. so that's a good thing. in terms of what people should do about this, they should still have the vaccine but they need to be informed and they need to have a choice of whether to have it or not —— suspicion arose. there will be people who become more hesitant because of this particular risk, and they need to have an opportunity to have a discussion with a health professional and way of those risk carefully because there is a risk of not vaccinating as well. you specialise — not vaccinating as well. you specialise in _ not vaccinating as well. you specialise in vaccine - not vaccinating as well. you specialise in vaccine hesitancy. there's this idea of vaccine competence, potentially being dented. how do you counter th

well now some more concerns over the astra zeneca vaccine oxford university has poorest testing that shot on children pending an investigation into rare blood clots and adults who have received the jab now the university says it's just a precautionary measure and there are no safety concerns in the pediatric clinical trial more than 200 children aged 6 to 17 were taking past the european medicines agency is due to announce its findings into any link between the vaccine crossing later on wednesday well it's now speak to china how is outside a vaccination center for us in london now john all eyes i imagine on the u.k. is medicines regulators as it sides whether the rollout of astra zeneca as even safe to continue. well both of those regulators as you say conducting their own reviews and we await their findings some suggestion that the regulator here in the u.k. the m h r a may update its guidance today or tomorrow to exclude the rollout of the astra zeneca vaccine among younger adults we know about that oxford trial that was halted on tuesday night the even oxford saying they had no sa

it's chilly on oxford street.hey will probably need a few extra laborers but such is the pent-up demand here in the u.k. that the expectation is that many people will take advantage of these new freedoms. certainly, that is the hope of a number of the stores. we have spoken to a number of people in the retail industry, and they have been spending a lot of money to make their stores ready, make them feel covid safe. a lot of hand sanitizer, plexi grass -- plexiglass. mark: good morning. very exciting to see oxford street behind you. do you think we will get some people there for tourism, just the novelty of shopping? we talk about the cost of the pandemic for u.k. retailers. do we think we now consider the pandemic behind us for u.k. retailers? do you think it will be a slow reopening? emma: that is a very important question i think in terms of what happens once the euphoria of the reopening has passed. our expectations are that people will come to the stores today and over the next week as we get used to the novel

there is a conversation, _ instead of the oxford vaccine?y, some people have said, can i have this one all that one? some people say, the messenger rna one from the pfizer one, we haven't had that child —— that in trial over ten years, the oxford astrazeneca one is much more familiar as a type. now we are going to get the moderna one which is coming out in the next few weeks which is almost identical to the pfizer one. unfortunately we have no say in it, what we are given is what we are given and as far as we know, and what the evidence is, they are the same in every way of effectiveness but also in the side effects. the agency will come back in the next couple of days to say why they stopped that roll—out for children. the children, it is very different. we are talking about much younger people here. people over 50, which i am part of, that doesn't seem to be an extra risk to them at all. ~ , ,., ~' seem to be an extra risk to them at all. . , ., seem to be an extra risk to them at all. ~ ., all. we spoke to the vaccine minister nadhim _ al

news and world report, oxford university? who are you to question the justifications of dr. fauci? who are you to tell those doctors you don't know what you're talking about. i would refer to you, why are you questioning those who question dr. fauci? they have farmer impressive diplomas and accreditations, ma'am, then you do. host: let's go to johnny from tacoma, washington. caller: good morning. i just want to say to steve. you are on here promoting your book and dr. fauci is a scientist and we have to understand science. so at one point we might say that you don't need masks, but with science and then you realize that out there without masks this is spreading faster. so you regroup and say, ok, maybe we do need masks paid you try different things and you tell the people who lost family members. we had over half a million people to die from this. this herd immunity who was talking to trump about letting it go. how many people do we want to die before we say we need to do something like quarantined? i am a schoolteacher, so i understand how quarantining students and doing virtual l

- confidently receive the oxford astrazeneca _ confidently receive the oxford astrazeneca vaccine _on- astrazeneca vaccine if it is offered to me. the second question i- astrazeneca vaccine if it is offered | to me. the second question i want astrazeneca vaccine if it is offered i to me. the second question i want to ask is— to me. the second question i want to ask is that _ to me. the second question i want to ask is that europe _ to me. the second question i want to ask is that europe remains— to me. the second question i want to ask is that europe remains one - to me. the second question i want to ask is that europe remains one of- ask is that europe remains one of the most — ask is that europe remains one of the most vaccine _ ask is that europe remains one of the most vaccine sceptical- ask is that europe remains one of. the most vaccine sceptical continent in the _ the most vaccine sceptical continent in the world — the most vaccine sceptical continent in the world. will— the most vaccine sceptical continent in the world. will allowing _ the most vaccine sceptical continent in

the team at the university of oxford looked over half a million the team at the university of oxfordting the brain were more common in those who'd had covid. they looked at 11t conditions including anxiety, depression and psychosis, stroke, brain haemorrhage, and dementia. all of these conditions were seen more often in people who'd had a covid infection in the previous six months. but these conditions all have very different causes. it could be that in some people, the virus actually gets into the brain and causes some damage. it could be the way your body is reacting to the virus, produces a sort of immune or inflammatory response that, again, contributes to the problems. and for other people, it may simply be a psychological effect, if you like, of the stress that having covid and thinking what might happen to you next is the important factor. the study couldn't prove the virus itself was definitely causing the changes, but patients recovering from covid were more likely than similar people who'd had flu or another infection to develop a psychological or neurological condition. an

. >> amy: the consequence of the contract between oxford and astrazeneca with the serum institute india, just to explain for people to understand what is taking place and the role of these large pharmaceutical companies? >> [indiscernible] the rule is you have to have at least three suppliers. if you look at india, it has many manufacturers. the decision to go and have -- it started with oxford printing astrazeneca -- the monopoly is going to cost us. [indiscernible] astrazeneca is in a difficult position. it hlias to vaccinate at a fastr pace and at the same time ensure these vaccines go to the developing world. this is a difficult point in india's policy acres. i would not want to be in their shoes today. amy: you right the billions of means of doses are not for rich countries and not even for india alone there for all 92 of the poorest countries in the world. the bulk of india's vaccination goals were being met by just one supplier, which faces the impossible choice of either letting down the other 91 countries depending on it or offending its own government. can you talk more abo

for the oxford - roll-outs. absolutely the same - phrase.ford astrazeneca jab, certainly fights over contracts and deliveries and there were these concerns around his blood clots. talking about these numbers of people and also only possible banks of the stage ii of blood clots. these blood clots can be fatal. and so, this was done in children with the jab. children not yet received this in the risk, the interesting thing worth highlighting is that the risk of these blood clots being seen in younger women and so, not the people most vulnerable to covid—19. there's a question of whether it is correct in those circumstances to continue vaccinating people who are otherwise pretty healthy, and hope the age group, given if there is a risk of something that is so dangerous. but of course, that risk is very tiny and the greater good from everybody being vaccinated is enormous. , , ., , ., enormous. this is the 'ab for the world and — enormous. this is the 'ab for the world and the t enormous. this is the jab for the world and the consequences - enor

the oxford astra zeneca vaccine and comfortable scrutiny medicines regulators in the u.k. and the e.u. have judged that its benefits outweigh any possible risks but they haven't ruled out a calls a link between the vaccine and rare blood clot conditions in a tiny number of recipients based on the current evidence the benefits of the covert 900 facts in astra zeneca against covert 90 and its associated risks hospitalization and death continues to outweigh the risks for the vast majority of people. our review has reinforced that the risk of this fred suspected side effect remains extremely small in arms today the european medicines agency said there was insufficient data to isolate risk factors like age and gender and that blood clotting should be listed as a possible side effect of the jab this case also shows us that our pharmacovigilance system is working these very rare and unusual events have been picked up identified analyzed and loudest to come to science based recommendations to allow the safe and effective use of this vaccine investigations into the astra zeneca vac

on a straight course, oxford, _ allsorts of problems.t, - allsorts of problems. on a straight l course, oxford, on the right, almost veered into the path of cambridge, but the light blues fought back and found their rhythm. bhd but the light blues fought back and found their rhythm.— found their rhythm. and they have that feeling _ found their rhythm. and they have that feeling now, _ found their rhythm. and they have that feeling now, cambridge, - found their rhythm. and they have l that feeling now, cambridge, across the finish line.— the finish line. living up to their billin: as the finish line. living up to their billing as favourites, _ the finish line. living up to their billing as favourites, to - the finish line. living up to their billing as favourites, to win - the finish line. living up to their billing as favourites, to win for. billing as favourites, to win for the fourth successive time. history had been made before the men's race even started, as in sarah winckless became its first female umpire. under her watch, both tea

i'm joined now by kareena hoyer from oxford economics she is the managing director for a year up there and scott lipinski c.e.o. of the german fashion council welcome to you both glad to see we're all dressed for the occasion scott i'd like to start with you the shift in consumer taste as to what we call pandemic chic casual loungewear and such that's been an almost global phenomenon but what has that done to the fashion industry. for sure there are a couple of winners and the fashion industry where this increase in revenue trends are all the casual wear but those brands and those companies are not the only ones actually who make the fashion industry so we have formal wear brands we have evening wear brands we have business where parents and all of them actually have a decrease in revenue and it's not just the brands itself so we also should think about everyone participating and aligned with the supply chain so it's the manufacturers maybe not also in germany but globally it's there in the the partner is not these brands work with they're also suffering under these circumstances so it

well the researchers from oxford have said that they want to conduct the needed trials within the next 2 years so 2 years is their. time frame at the moment but then of course there are the vaccine would still have to go through in a poorer process as we all know from the covert vaccines and there's still a few things that can go wrong on the way so we really have to see what these for other trials will give us more i will fingers crossed thank you meredith every science editor. well since the start of the muslim holy month of ramadan nearly 2 weeks ago there have been nightly clashes between palestinians and israeli police in jerusalem tensions were not stop a level on thursday when hundreds of far right jewish demonstrators took to the straits calling for arabs to leave the country saturday night saw yet another protest but a peaceful one as dozens turned out to raise their voices against hatred and violence. doesn't spill jerusalem zion square to make their voices heard to call for peace and unity and to condemn what they see is a burgeoning movement of jewish supremacy this is the

a new study by oxford university has fun the risk of developing blood clots from having the fines or and the dern a covert vaccines is about the same as the under-fire. job now the study involved more than a 1000000 people according to the oxford findings for in those 1000000 tests experienced clotting with the pfizer m a durn of vaccines while it was fun even 1000000 for the astra zeneca jump like in person a 39 in a 1000000 risk of clotting for those suffering from covert itself we've got reaction to the story from a number of guest. they get murdered are sort of daily reports of how many people are charged as are within a month. of having one with the car but since these will soon mitsu not if they are constantly sent since phones are very vocal school because school people with them are proud are the roll out some who shoot assess the effectiveness of the rollout because we must remember always but see this parent especially this parent also about 2023 and the public needs to be in school so not being in schools are so short but our experiment what's happening is all these are re

amber rudd, for instance, was no platforms at oxford university— instance, was no platforms at oxfordpt, she ended up speaking in the end. when the university insisted _ the end. when the university insisted. she didn't seem to be seeing — insisted. she didn't seem to be seeing if we don't like your views and we _ seeing if we don't like your views and we don't want used to debate these _ and we don't want used to debate these topics that are taboo, and among — these topics that are taboo, and among this has been things that transgender issues, brexit, colonialism, then we are not going to give _ colonialism, then we are not going to give you — colonialism, then we are not going to give you platform to speak, even if you _ to give you platform to speak, even if you are _ to give you platform to speak, even if you are invited we are going to protest _ if you are invited we are going to protest and make it so difficult for you to _ protest and make it so difficult for you to top — protest and make it so difficult for you to top that you won't be able to debate _ you to top that you won'

will there be new advice regarding the oxford—astrazeneca vaccine?s medicines regulator and the european medicines agency are currently investigating a possible link with rare blood clots in younger adults. they are due to updated advice later today or on thursday. in the uk, trial of the vaccine on children in the uk has temporarily been halted. the university of oxford has told the bbc that there are no safety concerns with the trial itself. 0ur medical editor, fergus walsh, reports. nearly 300 children, aged 6—17 are taking part in the astrazeneca vaccine trial in england which began in february. 0xford england which began in february. oxford university said there had been no blood clots and volunteers but out of an abundance of caution it had stopped vaccinations pending the outcome of the safety review in adults. more than 18 million people in the uk have received the astrazeneca vaccine. the mhra said last week the happy 30 rare cases of blood clots including seven deaths. —— there had been 30 rare cases. the prime minister, visiting an astraze